PureTech Health plc (LON:PRTC - Get Free Report)'s share price traded up 14.6% during mid-day trading on Saturday . The company traded as high as GBX 118 ($1.57) and last traded at GBX 118 ($1.57). 1,623,564 shares changed hands during mid-day trading, an increase of 54% from the average session volume of 1,056,594 shares. The stock had previously closed at GBX 103 ($1.37).
PureTech Health Trading Up 0.8 %
The company has a market cap of £370.67 million, a P/E ratio of -5.06 and a beta of 1.02. The company has a current ratio of 3.68, a quick ratio of 2.51 and a debt-to-equity ratio of 45.82. The stock's 50 day moving average is GBX 133.46 and its 200-day moving average is GBX 147.37.
PureTech Health Company Profile
(
Get Free Report)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Read More
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
